Syneos Health, Inc. Profile Avatar - Palmy Investing

Syneos Health, Inc.

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinic…

Medical - Diagnostics & Research
US, Morrisville [HQ]

Cash Flow Statements

12 Records · Starting from 2011
In Million USD. Margins, Growth Rates In %
Metric 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Operating Activities
Operating Cash Flow (OCF)
-18.00 42.00 37.00 131.00 204.00 109.00 198.00 303.00 318.00 425.00 450.00 426.00
Operating Cash (Net)
-18.00 42.00 37.00 131.00 204.00 109.00 198.00 303.00 318.00 425.00 450.00 426.00
Accounts Receivable
- - - - - - -24.00 -54.00 -103.00 31.00 -97.00 -120.00 16.00 -109.00 -88.00
Accounts Payable
- - - - - - 25.00 8.00 6.00 -16.00 60.00 28.00 -2.00 24.00 20.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-369.00 -12.00 -17.00 -27.00 -21.00 -31.00 -1,722.00 -145.00 -81.00 -504.00 -340.00 -105.00
Capital Expenditure
-4.00 -9.00 -17.00 -25.00 -21.00 -31.00 -43.00 -54.00 -63.00 -50.00 -56.00 -93.00
Purchases of Investments
- - - - - - - - - - - - - - - - - - - - - - - -
Sale/Maturity of Investment
- - - - - - - - - - - - - - - - - - - - - - - -
Property, Plant, Equipment (P&PE)
-4.00 -9.00 -17.00 -25.00 -21.00 -31.00 -43.00 -54.00 -63.00 -50.00 -56.00 -93.00
Acquisitions (Net)
-364.00 -3.00 - - -2.00 - - - - -1,678.00 -90.00 -17.00 -454.00 -284.00 -12.00
Other Investing Activities
- - - - - - - - - - - - - - - - -16.00 2.00 1.00 -7.00
Financing Activities
Used Cash (Net)
-422.00 -18.00 -6.00 -67.00 -211.00 -53.00 -1,734.00 -319.00 -215.00 -178.00 -277.00 -339.00
Debt Repayment
-329.00 -13.00 -6.00 -503.00 -490.00 -105.00 -865.00 -424.00 -892.00 -650.00 -823.00 -2,063.00
Dividends Paid
-4.00 - - - - - - - - - - - - - - - - - - - - - -
Common Stock
164 3 4 159 286 64 - - 74 56 70 117 173
Other Financing Activities
596.00 -2.00 1.00 283.00 565.00 116.00 2,600.00 179.00 734.00 898.00 662.00 1,851.00
Cash Balances
Begin of Period
40.00 70.00 81.00 96.00 126.00 85.00 102.00 321.00 155.00 163.00 272.00 106.00
End of Period
70.00 81.00 96.00 126.00 85.00 102.00 321.00 155.00 163.00 272.00 106.00 112.00
Change
30.00 10.00 15.00 29.00 -41.00 17.00 218.00 -166.00 7.00 108.00 -165.00 5.00
Non-Cash Balances
Depreciation and Amortization
64.00 78.00 58.00 54.00 56.00 59.00 179.00 273.00 242.00 222.00 235.00 247.00
Stock Based Compensation
1.00 1.00 2.00 3.00 5.00 14.00 59.00 34.00 55.00 58.00 65.00 57.00
Other
7.00 8.00 8.00 66.00 14.00 24.00 35.00 -25.00 22.00 -2.00 5.00 -15.00
Highlighted metrics
Free Cash Flow (FCF)
-23.00 33.00 19.00 105.00 183.00 77.00 154.00 248.00 254.00 375.00 393.00 333.00
Cash Conversion Cycle (CCC)
- - 91.00 86.00 76.00 69.00 80.00 128.00 94.00 88.00 98.00 96.00 100.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of SYNH's Analysis
CIK: 1610950 CUSIP: 87166B102 ISIN: US87166B1026 LEI: - UEI: -
Secondary Listings
SYNH has no secondary listings inside our databases.